Although the etiology of Alzheimer's disease (AD) is not fully understood, nevertheless, inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activity has been accepted as an effective treatment/management strategy against mild AD [6, 7]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.